170 related articles for article (PubMed ID: 35550234)
1. Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain.
Chin AWH; Lai AMY; Peiris M; Man Poon LL
Emerg Infect Dis; 2022 Aug; 28(7):1515-1517. PubMed ID: 35550234
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
Mefsin YM; Chen D; Bond HS; Lin Y; Cheung JK; Wong JY; Ali ST; Lau EHY; Wu P; Leung GM; Cowling BJ
Emerg Infect Dis; 2022 Sep; 28(9):1856-1858. PubMed ID: 35914518
[TBL] [Abstract][Full Text] [Related]
3. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
Vauhkonen H; Nguyen PT; Kant R; Plyusnin I; Erdin M; Kurkela S; Liimatainen H; Ikonen N; Blomqvist S; Liitsola K; Lindh E; Helve O; Jarva H; Loginov R; Palva A; Hannunen T; Hannula S; Parry M; Kauppi P; Vaheri A; Sironen T; Lappalainen M; Savolainen-Kopra C; Smura T; Vapalahti O
Emerg Infect Dis; 2022 Jun; 28(6):1229-1232. PubMed ID: 35378057
[TBL] [Abstract][Full Text] [Related]
4. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
[TBL] [Abstract][Full Text] [Related]
5. Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan.
Shao PL; Tu HC; Gong YN; Shu HY; Kirby R; Hsu LY; Yeo HY; Kuo HY; Huang YC; Lin YF; Weng HY; Wu YL; Chen CC; Chen TW; Lee KM; Huang CG; Shih SR; Chen WJ; Wu CC; Yu CJ; Tsai SF
Emerg Infect Dis; 2023 Apr; 29(4):792-796. PubMed ID: 36918378
[TBL] [Abstract][Full Text] [Related]
6. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
[TBL] [Abstract][Full Text] [Related]
7. Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
Kim EY; Choe YJ; Park H; Jeong H; Chung JH; Yu J; Ko HP; Ahn HJ; Go MY; Lee JH; Kim WI; Lee BS; Kim S; Yu M; Kim J; Lee HR; Jang EJ; Lee JJ; Lee HY; Kim JM; Choi JH; Lee SE; Kim IH; Park AK; Rhee JE; Kim EJ; Lee S; Park YJ
Emerg Infect Dis; 2022 Apr; 28(4):898-900. PubMed ID: 35171760
[TBL] [Abstract][Full Text] [Related]
8. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
Paz M; Aldunate F; Arce R; Ferreiro I; Cristina J
Virus Res; 2022 Jun; 314():198753. PubMed ID: 35331836
[TBL] [Abstract][Full Text] [Related]
9. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
[TBL] [Abstract][Full Text] [Related]
10. Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore.
Zeng K; Santhya S; Soong A; Malhotra N; Pushparajah D; Thoon KC; Yeo B; Ho ZJM; Cheng MCI
Emerg Infect Dis; 2023 Apr; 29(4):814-817. PubMed ID: 36878009
[TBL] [Abstract][Full Text] [Related]
11. Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern.
Bushmaker T; Yinda CK; Morris DH; Holbrook MG; Gamble A; Adney D; Bushmaker C; van Doremalen N; Fischer RJ; Plowright RK; Lloyd-Smith JO; Munster VJ
Emerg Infect Dis; 2023 May; 29(5):1033-1037. PubMed ID: 37054984
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico.
Santiago GA; Volkman HR; Flores B; González GL; Charriez KN; Huertas LC; Van Belleghem SM; Rivera-Amill V; Major C; Colon C; Tosado R; Adams LE; Marzán M; Hernández L; Cardona I; O'Neill E; Paz-Bailey G; Papa R; Muñoz-Jordan JL
Emerg Infect Dis; 2023 Apr; 29(4):855-857. PubMed ID: 36878014
[TBL] [Abstract][Full Text] [Related]
13. Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021.
Kremer C; Braeye T; Proesmans K; André E; Torneri A; Hens N
Emerg Infect Dis; 2022 Aug; 28(8):1699-1702. PubMed ID: 35732195
[TBL] [Abstract][Full Text] [Related]
14. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
Pedersen RM; Bang LL; Madsen LW; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE
Emerg Infect Dis; 2022 Jun; 28(6):1274-1275. PubMed ID: 35356875
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda.
Mugisha J; Mpairwe B; Newton R; Cotten M; Phan MVT
Emerg Infect Dis; 2023 Jan; 29(1):224-226. PubMed ID: 36529453
[TBL] [Abstract][Full Text] [Related]
16. Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sublineage.
Mak GCK; Lau SSY; Wong KKY; Lau CS; Ng KHL; Lam ETK; Chan RCW
J Med Virol; 2022 Oct; 94(10):5033-5037. PubMed ID: 35656593
[TBL] [Abstract][Full Text] [Related]
17. Two Cases of Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections Caused by the Omicron Variant (B.1.1.529 Lineage) in International Travelers to Japan.
Maruki T; Iwamoto N; Kanda K; Okumura N; Yamada G; Ishikane M; Ujiie M; Saito M; Fujimoto T; Kageyama T; Saito T; Saito S; Suzuki T; Ohmagari N
Clin Infect Dis; 2022 Aug; 75(1):e354-e356. PubMed ID: 34979547
[TBL] [Abstract][Full Text] [Related]
18. Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
Song JS; Lee J; Kim M; Jeong HS; Kim MS; Kim SG; Yoo HN; Lee JJ; Lee HY; Lee SE; Kim EJ; Rhee JE; Kim IH; Park YJ
Emerg Infect Dis; 2022 Mar; 28(3):756-759. PubMed ID: 35107418
[TBL] [Abstract][Full Text] [Related]
19. Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022.
Foulkes S; Monk EJM; Sparkes D; Hettiarachchi N; Milligan ID; Munro K; Taylor-Kerr A; Platt N; Howells A; Kyaw JYA; Adaji E; Gallagher E; Khawam J; Wellington E; Price L; Crossman D; Norman C; de Lacy E; Cromey L; Corrigan D; Lackenby A; Barbero P; Elegunde B; Zambon M; Chand MA; Brown CS; Islam J; Atti A; Hopkins S; Hall VJ; Cole MJ;
Emerg Infect Dis; 2023 Jan; 29(1):184-188. PubMed ID: 36454718
[TBL] [Abstract][Full Text] [Related]
20. Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA.
Seid AG; Yirko T; Sayeed S; Plipat N
Emerg Infect Dis; 2022 Sep; 28(9):1911-1913. PubMed ID: 35914519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
